<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Russian veterinary journal</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Russian veterinary journal</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Российский ветеринарный журнал</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2500-4379</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">59174</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>ДЕРМАТОЛОГИЯ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>DERMATOLOGY</subject>
    </subj-group>
    <subj-group>
     <subject>ДЕРМАТОЛОГИЯ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Development and validation of an owner-assessed Visual Analog Scale for feline pruritus severity scoring (VAScat)</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Разработка и проверка визуальной аналоговой шкалы для оценки тяжести зуда у кошек владельцами (VAScat)</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Коломбо</surname>
       <given-names>Сильвия </given-names>
      </name>
      <name xml:lang="en">
       <surname>Kolombo</surname>
       <given-names>Sil'viya </given-names>
      </name>
     </name-alternatives>
     <email>colombo_silvia@yahoo.it</email>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Сартори</surname>
       <given-names>Роберта </given-names>
      </name>
      <name xml:lang="en">
       <surname>Sartori</surname>
       <given-names>Roberta </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Скьевано</surname>
       <given-names>Карло </given-names>
      </name>
      <name xml:lang="en">
       <surname>Sk'evano</surname>
       <given-names>Karlo </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Борио</surname>
       <given-names>Стефано </given-names>
      </name>
      <name xml:lang="en">
       <surname>Borio</surname>
       <given-names>Stefano </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Ветеринарные дерматологические услуги</institution>
     <city>Леньяно</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Servizi Dermatologici Veterinari</institution>
     <city>Legnano</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Ветеринарные дерматологические услуги</institution>
     <city>Милан</city>
     <country>Италия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Servizi Dermatologici Veterinari</institution>
     <city>Milano</city>
     <country>Italy</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Новационное статистическое исследование,</institution>
     <city>Падуя</city>
     <country>Италия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Innovative Statistical Research</institution>
     <city>Padova</city>
     <country>Italy</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Университет Калифорнии</institution>
     <city>Дэвис</city>
     <country>США</country>
    </aff>
    <aff>
     <institution xml:lang="en">University of California</institution>
     <city>Davis</city>
     <country>United States of America</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2023-04-14T17:28:23+03:00">
    <day>14</day>
    <month>04</month>
    <year>2023</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2023-04-14T17:28:23+03:00">
    <day>14</day>
    <month>04</month>
    <year>2023</year>
   </pub-date>
   <volume>2023</volume>
   <issue>1</issue>
   <fpage>47</fpage>
   <lpage>53</lpage>
   <history>
    <date date-type="received" iso-8601-date="2023-04-14T00:00:00+03:00">
     <day>14</day>
     <month>04</month>
     <year>2023</year>
    </date>
   </history>
   <self-uri xlink:href="https://logospress.editorum.ru/en/nauka/article/59174/view">https://logospress.editorum.ru/en/nauka/article/59174/view</self-uri>
   <abstract xml:lang="ru">
    <p>Предпосылки: у кошек сложно оценить тяжесть зуда, так как дискомфорт у них проявляется усиленным вылизыванием и (или) расчесыванием.&#13;
Гипотеза/цели: нашей целью была разработка и проверка достоверности шкалы оценки зуда специально для кошек (VAScat).&#13;
Методы: шкала была разработана как двойная визуальная аналоговая шкала (ВАШ), одна для оценки вылизывания и вторая — расчесывания, с ключевыми словами для описания тяжести проявлений и поведения. Зуд у каждой кошки оценивали по высочайшему баллу (ВАШ-макс.) по любой из ВАШ. Владельцы 153 кошек с кожными заболеваниями и 108 здоровых кошек оценивали зуд у своих кошек с помощью шкалы VAScat. 96 из 153 кошек с кожными заболеваниями также оценивали повторно через 4–8 недель лечения.&#13;
Результаты: коэффициент корреляции Пирсона между оценками по ВАШ вылизывания и ВАШ зуда составил r = 0,26 (p &lt; 0,01), а значение альфа Кронбаха ‒ 0,41. Оба индекса показали, что две шкалы измеряют разные проявления зуда и поддерживают использование двойной системы оценки. Сравнение с числовой шкалой тяжести зуда (0, отсутствует; 1, легкий; 2, умеренный; 3, сильный) дает основания полагать, что ВАШ вылизывания и ВАШ расчесывания по отдельности не подходят для измерения зуда от отсутствующего до легкого (степени 0…1), тогда как ВАШ-макс. ‒ подходит (p = 0,001). Все шкалы — ВАШ вылизывания, ВАШ расчесывания и ВАШ-макс. ‒ подходили для оценки более высоких степеней зуда (2///3, p &lt; 0,01). Шкала VAScat позволяла измерить снижение зуда после лечения, так как оценки после лечения значительно снизились по сравнению с оценками до лечения (p &lt; 0,0001).&#13;
Выводы и клиническая значимость: шкала VAScat показала себя полезным инструментом для оценки зуда у кошек и наблюдения за ответом на лечение зуда.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Background: Assessment of the severity of pruritus is difficult in cats, because they manifest discomfort by increased licking, increased scratching or both.&#13;
Hypothesis/Objectives: Our objective was to develop and validate a feline specific pruritus scale (VAScat).&#13;
Methods: The scale was designed as a double Visual Analog Scale (VAS), one VAS for licking and one for scratching, with severity and behavioural descriptors. The highest score (VAS-max) on either VAS was taken as the pruritus score for each cat. Owners of 153 cats with skin diseases and of 108 healthy cats scored their pet's pruritus using the VAScat. Ninety-six of 153 cats with skin diseases also were re-evaluated after four to eight weeks of treatment.&#13;
&#13;
Results: Pearson's correlation value between VAS-licking and VAS-scratching scores was r =0.26 (p &lt;0.01), and Cronbach's alpha was 0.41. Both indexes indicated that the two scales measure different manifestations of pruritus and supported the use of a dual assessing system. Comparison with a numerical pruritus severity scale (0, absent; 1, mild; 2, moderate; 3, severe) suggested that VAS-licking and VAS-scratching scales taken alone are unsuitable for measuring absent to mild pruritus (grades 0…1), while VAS-max is (p =0.001). VAS-licking, VAS-scratching and VAS-max all were suitable to assess higher levels of pruritus (grades 2…3, p &lt;0.01). The VAScat was able to measure pruritus improvement following therapy, as post-treatment scores were significantly decreased compared to pre-treatment ones (p &lt;0.0001).&#13;
Conclusions and clinical importance: The VAScat proved to be a useful tool to assess pruritus in cats and for monitoring the response to treatment for pruritus.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>кошка</kwd>
    <kwd>зуд</kwd>
    <kwd>визуальная аналоговая шкала (ВАШ)</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>cat</kwd>
    <kwd>pruritus</kwd>
    <kwd>visual analog scale (VAS)</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pereira M.P., Ständer S., Assessment of severity and burden of pruritus, Allergol Int. 2017, No. 66, pp. 3-7.</mixed-citation>
     <mixed-citation xml:lang="en">Pereira M.P., Ständer S., Assessment of severity and burden of pruritus, Allergol Int. 2017, No. 66, pp. 3-7.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hill P.B., Lau P., Rybnicek J., Development of an owner-assessed scale to measure the severity of pruritus in dogs, Vet Dermatol., 2007, No. 18, pp. 301-318.</mixed-citation>
     <mixed-citation xml:lang="en">Hill P.B., Lau P., Rybnicek J., Development of an owner-assessed scale to measure the severity of pruritus in dogs, Vet Dermatol., 2007, No. 18, pp. 301-318.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rybnicek J., Lau-Gillard P., Harvey R., Hill P.B., Further validation of a pruritus severity scale for use in dogs, Vet Dermatol., 2008, No. 20, pp. 115-22.</mixed-citation>
     <mixed-citation xml:lang="en">Rybnicek J., Lau-Gillard P., Harvey R., Hill P.B., Further validation of a pruritus severity scale for use in dogs, Vet Dermatol., 2008, No. 20, pp. 115-22.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Nuttall T.J., McEwan N.A., Bensignor E., Cornegliani L., Löwenstein C., Rème C.A.m Comparable efficacy of a topical 0.0584 % hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis, Vet Dermatol., 2011, No. 23, pp.4-12.</mixed-citation>
     <mixed-citation xml:lang="en">Nuttall T.J., McEwan N.A., Bensignor E., Cornegliani L., Löwenstein C., Rème C.A.m Comparable efficacy of a topical 0.0584 % hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis, Vet Dermatol., 2011, No. 23, pp.4-12.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cosgrove S.B., Cleaver D.M., King V.L, Gilmer A.R., Daniels A.E., Wren J.A .et al.m Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life, Vet Dermatol., 2015, No. 26, pp. 171-180.</mixed-citation>
     <mixed-citation xml:lang="en">Cosgrove S.B., Cleaver D.M., King V.L, Gilmer A.R., Daniels A.E., Wren J.A .et al.m Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life, Vet Dermatol., 2015, No. 26, pp. 171-180.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Noli C., della Valle M.F., Miolo A., Medori C., Schievano C., Skinalia Clinicl Research Group. Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study, Vet Dermatol, 2015, No. 26, pp. 432-434.</mixed-citation>
     <mixed-citation xml:lang="en">Noli C., della Valle M.F., Miolo A., Medori C., Schievano C., Skinalia Clinicl Research Group. Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study, Vet Dermatol, 2015, No. 26, pp. 432-434.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Moyaert H., Van Brussel L., Borowski S., Escalada M., Mahabir S.P., Walters R.R. et al., A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis, Vet Dermatol., 2017, No. 28, pp. 593-e145.</mixed-citation>
     <mixed-citation xml:lang="en">Moyaert H., Van Brussel L., Borowski S., Escalada M., Mahabir S.P., Walters R.R. et al., A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis, Vet Dermatol., 2017, No. 28, pp. 593-e145.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Bensignor E.J., Fabries L.J., Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study, Vet Dermatol. 2018, No. 29, pp. 446-e150.</mixed-citation>
     <mixed-citation xml:lang="en">Bensignor E.J., Fabries L.J., Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study, Vet Dermatol. 2018, No. 29, pp. 446-e150.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gonzales J.L., Zalve V., Fernández-Caldas E., Cases B., Subiza J-L., Casanovas M., A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells, Vet Dermatol., 2018, No. 29, pp. 449-e152.</mixed-citation>
     <mixed-citation xml:lang="en">Gonzales J.L., Zalve V., Fernández-Caldas E., Cases B., Subiza J-L., Casanovas M., A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells, Vet Dermatol., 2018, No. 29, pp. 449-e152.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Timm K., Mueller R.S., Nett-Mettler C.S., Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis, Vet Dermatol., 2018, No. 29, pp. 123-e49.</mixed-citation>
     <mixed-citation xml:lang="en">Timm K., Mueller R.S., Nett-Mettler C.S., Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis, Vet Dermatol., 2018, No. 29, pp. 123-e49.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Souza P.C., Rosychuck R.A.W., Contreras E.T., Schissler J.R., Simpson A.C., A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA, Vet Dermatol., 2018, No. 29, pp. 489-e164.</mixed-citation>
     <mixed-citation xml:lang="en">Souza P.C., Rosychuck R.A.W., Contreras E.T., Schissler J.R., Simpson A.C., A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA, Vet Dermatol., 2018, No. 29, pp. 489-e164.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Osumi T., Shimada T., Sakaguchi M., Tsujimoto H., A double-blind, placebo-controlled evaluation of orally administered heat-killed Enterococcus faecalis FK-23 preparation in atopic dogs, Vet Dermatol., 2019, No. 30, pp. 127-e26.</mixed-citation>
     <mixed-citation xml:lang="en">Osumi T., Shimada T., Sakaguchi M., Tsujimoto H., A double-blind, placebo-controlled evaluation of orally administered heat-killed Enterococcus faecalis FK-23 preparation in atopic dogs, Vet Dermatol., 2019, No. 30, pp. 127-e26.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Fischer N.M., Rostaher A., Favrot C., A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis, Vet Dermatol., 2020, No. 31, pp. 365-e96.</mixed-citation>
     <mixed-citation xml:lang="en">Fischer N.M., Rostaher A., Favrot C., A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis, Vet Dermatol., 2020, No. 31, pp. 365-e96.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Marsella R., Ahrens K., Wilkes R., Trujillo A., Dorr M., Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs, Vet Dermatol., 2020, No. 31, pp. 284-e69.</mixed-citation>
     <mixed-citation xml:lang="en">Marsella R., Ahrens K., Wilkes R., Trujillo A., Dorr M., Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs, Vet Dermatol., 2020, No. 31, pp. 284-e69.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Santoro D., Fagman L., Zhang Y., Fahong Y., Clinical efficacy of spray-based heat-treated lactobacilli in canine atopic dermatitis: a preliminary, open-label, uncontrolled study, Vet Dermatol., 2021, No. 32, pp. 114-e23.</mixed-citation>
     <mixed-citation xml:lang="en">Santoro D., Fagman L., Zhang Y., Fahong Y., Clinical efficacy of spray-based heat-treated lactobacilli in canine atopic dermatitis: a preliminary, open-label, uncontrolled study, Vet Dermatol., 2021, No. 32, pp. 114-e23.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hobi S., Klinger C., Classen J., Mueller R.S., The effects of a topical lipid complex therapy on dogs with atopic dermatitis: a double blind, randomized, placebo-controlled study, Vet Dermatol., 2017, No. 28, pp. 369-e84.</mixed-citation>
     <mixed-citation xml:lang="en">Hobi S., Klinger C., Classen J., Mueller R.S., The effects of a topical lipid complex therapy on dogs with atopic dermatitis: a double blind, randomized, placebo-controlled study, Vet Dermatol., 2017, No. 28, pp. 369-e84.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hobi S., Linek M., Marignac G., Olivry T., Beco L., Nett C. et al., Clinical characteristics and causes of pruritus in cats: a multicenter study on feline hypersensitivity-associated dermatoses, Vet Dermatol., 2011, No. 22, pp. 406-413.</mixed-citation>
     <mixed-citation xml:lang="en">Hobi S., Linek M., Marignac G., Olivry T., Beco L., Nett C. et al., Clinical characteristics and causes of pruritus in cats: a multicenter study on feline hypersensitivity-associated dermatoses, Vet Dermatol., 2011, No. 22, pp. 406-413.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wildermuth K., Zabel S., Rosychuk R.A.W., The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study, Vet Dermatol., 2013, No. 24, pp. 576-581, e137-8.</mixed-citation>
     <mixed-citation xml:lang="en">Wildermuth K., Zabel S., Rosychuk R.A.W., The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study, Vet Dermatol., 2013, No. 24, pp. 576-581, e137-8.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ortalda C., Noli C., Colombo S., Borio S., Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats, Vet Dermatol., 2015, No. 26, pp. 235-e52.</mixed-citation>
     <mixed-citation xml:lang="en">Ortalda C., Noli C., Colombo S., Borio S., Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats, Vet Dermatol., 2015, No. 26, pp. 235-e52.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Koch S.N., Torres S.M.F., Diaz S., Gilbert S., Rendahl A., Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial, Vet Dermatol., 2018, No. 29, pp. 107-e43.</mixed-citation>
     <mixed-citation xml:lang="en">Koch S.N., Torres S.M.F., Diaz S., Gilbert S., Rendahl A., Subcutaneous administration of ciclosporin in 11 allergic cats - a pilot open-label uncontrolled clinical trial, Vet Dermatol., 2018, No. 29, pp. 107-e43.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Noli C., Matricoti I., Schievano C., A double-blinded, randomized, methylprednisolone-controlled study of the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis, Vet Dermatol., 2019, No. 30, pp. 110-e30.</mixed-citation>
     <mixed-citation xml:lang="en">Noli C., Matricoti I., Schievano C., A double-blinded, randomized, methylprednisolone-controlled study of the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis, Vet Dermatol., 2019, No. 30, pp. 110-e30.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Maina E., Fontaine J., Use of maropitant for the control of pruritus in non-flea, non-food- induced feline hypersensitivity dermatitis: an open-label uncontrolled pilot study, J Feline Med Surg., 2019, No. 21, pp. 967-72.</mixed-citation>
     <mixed-citation xml:lang="en">Maina E., Fontaine J., Use of maropitant for the control of pruritus in non-flea, non-food- induced feline hypersensitivity dermatitis: an open-label uncontrolled pilot study, J Feline Med Surg., 2019, No. 21, pp. 967-72.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Scott D.W., Rothstein E., Beningo K.E., Miller W.H., Observations on the use of cyproheptadine hydrochloride as an antipruritic agent in allergic cats, Can Vet J., 1998, No. 39, pp. 634-637.</mixed-citation>
     <mixed-citation xml:lang="en">Scott D.W., Rothstein E., Beningo K.E., Miller W.H., Observations on the use of cyproheptadine hydrochloride as an antipruritic agent in allergic cats, Can Vet J., 1998, No. 39, pp. 634-637.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Medleau L., Hnilica K.A., Lower K., Alva R., Clekis T., Case J. et al., Effect of topical application of fipronil in cats with flea allergic dermatitis, J Am Vet Med Assoc., 2002, No. 221, pp. 254-257.</mixed-citation>
     <mixed-citation xml:lang="en">Medleau L., Hnilica K.A., Lower K., Alva R., Clekis T., Case J. et al., Effect of topical application of fipronil in cats with flea allergic dermatitis, J Am Vet Med Assoc., 2002, No. 221, pp. 254-257.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Noli C., Scarampella F., Prospective open pilot study on the use of ciclosporin for feline allergic skin disease, J Small Anim Pract., 2006, No. 47, pp. 434-438.</mixed-citation>
     <mixed-citation xml:lang="en">Noli C., Scarampella F., Prospective open pilot study on the use of ciclosporin for feline allergic skin disease, J Small Anim Pract., 2006, No. 47, pp. 434-438.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wisselink M.A., Willemse T., The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study, Vet J., 2009, No. 180, pp. 55-59.</mixed-citation>
     <mixed-citation xml:lang="en">Wisselink M.A., Willemse T., The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study, Vet J., 2009, No. 180, pp. 55-59.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Griffin J.S., Scott D.W., Miller W.H., Tranchina M.M., An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats, Can Vet J., 2012, No. 53, pp. 47-50.</mixed-citation>
     <mixed-citation xml:lang="en">Griffin J.S., Scott D.W., Miller W.H., Tranchina M.M., An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats, Can Vet J., 2012, No. 53, pp. 47-50.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ganz E.C., Griffin C.E., Keys D.A., Flatgard T.A., Evaluation of methylprednisolone and triamcinolone for the induction and maintenance treatment of pruritus in allergic cats: a double-blinded, randomized, prospective study, Vet Dermatol., 2012, No. 23, pp. 387-e72.</mixed-citation>
     <mixed-citation xml:lang="en">Ganz E.C., Griffin C.E., Keys D.A., Flatgard T.A., Evaluation of methylprednisolone and triamcinolone for the induction and maintenance treatment of pruritus in allergic cats: a double-blinded, randomized, prospective study, Vet Dermatol., 2012, No. 23, pp. 387-e72.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">King S., Favrot C., Messinger L., Nuttall J., Forster S., Seewald W., A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis, Vet Dermatol., 2012, No. 23, pp. 440-e84.</mixed-citation>
     <mixed-citation xml:lang="en">King S., Favrot C., Messinger L., Nuttall J., Forster S., Seewald W., A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis, Vet Dermatol., 2012, No. 23, pp. 440-e84.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B30">
    <label>30.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Roberts E.S., Speranza C., Friberg C., Griffin C., Steffan J., Roycroft L. et al., Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis, J Feline Med Surg., 2016, No. 18, pp. 889-897.</mixed-citation>
     <mixed-citation xml:lang="en">Roberts E.S., Speranza C., Friberg C., Griffin C., Steffan J., Roycroft L. et al., Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis, J Feline Med Surg., 2016, No. 18, pp. 889-897.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B31">
    <label>31.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Beaver B.V., Feline Behavior: A guide for veterinarians, St Louis, MO: WB Saunders, 2003.</mixed-citation>
     <mixed-citation xml:lang="en">Beaver B.V., Feline Behavior: A guide for veterinarians, St Louis, MO: WB Saunders, 2003.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B32">
    <label>32.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Bowen J., Heath S., Behaviour Problems in Small Animals: Practical advice for the veterinary team. Philadelphia, PA: WB Saunders, 2005.</mixed-citation>
     <mixed-citation xml:lang="en">Bowen J., Heath S., Behaviour Problems in Small Animals: Practical advice for the veterinary team. Philadelphia, PA: WB Saunders, 2005.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B33">
    <label>33.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rodan I., Heath S., Feline Behavioral Health and Welfare. St Louis, MO: Elsevier, 2016.</mixed-citation>
     <mixed-citation xml:lang="en">Rodan I., Heath S., Feline Behavioral Health and Welfare. St Louis, MO: Elsevier, 2016.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B34">
    <label>34.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Eckstein R.A., Hart B.L., The organization and control of grooming in cats. Appl Anim Behav Sci., 2000, No. 68, pp. 131-140.</mixed-citation>
     <mixed-citation xml:lang="en">Eckstein R.A., Hart B.L., The organization and control of grooming in cats. Appl Anim Behav Sci., 2000, No. 68, pp. 131-140.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B35">
    <label>35.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Noli C., Della Valle M.F., Miolo A., Medori C., Schievano C., Skinalia Clinical Research Group. Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study. Vet Dermatol, 2019, No. 30, pp. 387-e117.</mixed-citation>
     <mixed-citation xml:lang="en">Noli C., Della Valle M.F., Miolo A., Medori C., Schievano C., Skinalia Clinical Research Group. Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study. Vet Dermatol, 2019, No. 30, pp. 387-e117.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B36">
    <label>36.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Langner M.D., Maibach H.I., Pruritus measurement and treatment. Clin Exp Dermatol., 2009, No. 34, pp. 285-288.</mixed-citation>
     <mixed-citation xml:lang="en">Langner M.D., Maibach H.I., Pruritus measurement and treatment. Clin Exp Dermatol., 2009, No. 34, pp. 285-288.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B37">
    <label>37.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Young A.J., Torres S.M.F., Koch S.N., Eisenschenk M.N.C., Rendahl A.K., Canine Pruritus Visual Analog Scale: how does it capture owners' perception of their pet's itching level? Vet Dermatol., 2019, No. 30, pp. 377-e111.</mixed-citation>
     <mixed-citation xml:lang="en">Young A.J., Torres S.M.F., Koch S.N., Eisenschenk M.N.C., Rendahl A.K., Canine Pruritus Visual Analog Scale: how does it capture owners' perception of their pet's itching level? Vet Dermatol., 2019, No. 30, pp. 377-e111.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B38">
    <label>38.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Noli C., Cena T., Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats, Vet Dermatol., 2015, No. 26, pp. 481-483.</mixed-citation>
     <mixed-citation xml:lang="en">Noli C., Cena T., Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats, Vet Dermatol., 2015, No. 26, pp. 481-483.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B39">
    <label>39.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Brame B.E., Canning P., Morris D.O., Drobatz K.J., Rook K., Cain C.L., Interobserver reliability of Feline Dermatitis Extent and Severity Index (FEDESI) and Scoring Feline Allergic Dermatitis (SCORFAD) and the relationship between lesion scores and pruritus, Vet Dermatol., 2021, No. 32, pp. 492-e135.</mixed-citation>
     <mixed-citation xml:lang="en">Brame B.E., Canning P., Morris D.O., Drobatz K.J., Rook K., Cain C.L., Interobserver reliability of Feline Dermatitis Extent and Severity Index (FEDESI) and Scoring Feline Allergic Dermatitis (SCORFAD) and the relationship between lesion scores and pruritus, Vet Dermatol., 2021, No. 32, pp. 492-e135.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
